Daiichi Sankyo Company (4568) Drug Pipeline

The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness

A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.

Daiichi Sankyo Company JP:4568 is currently developing the following drugs: Bevacizumab, R-Dxd, Bevacizumab, Ds-6000A, R-Dxd, Mvasi, Avastin, Carboplatin, Bevacizumab, Gemcitabine, Paclitaxel, Pegylated Liposomal Doxorubicin, R-Dxd, Raludotatug Deruxtecan, Ds-6000A, Mvasi, Avastin, Carboplatin, Pembrolizumab, Pemetrexed, Ds-1103A, Ds-3939A, Her3-Dxd, Trastuzumab Deruxtecan, Patritumab Deruxtecan, T-Dxd, Ds1025a, Trastuzumab Deruxtecan, Trastuzumab, Palbociclib, Endocrine Therapy, Pertuzumab, T-Dxd, Enhertu, Herceptin, Ibrance, Ifinatamab Deruxtecan, I-Dxd, Rosuvastatin, Atorvastatin, Ezetimibe, Bempedoic Acid, Rescue Medication, I-Dxd, Ifinatamab Deruxtecan, Datopotamab Deruxtecan, Dexamethasone Mouthwash, Atorvastatin, Ezetimibe, Bempedoic Acid, Cetuximab, Patritumab Deruxtecan, Sacituzumab Tirumotecan, Rescue Medications, Mk-1084, Darolutamide, Valemetostat, Carboplatin, Etoposide, Atezolizumab, Gocatamig, I-Dxd, Rescue Medications, Docetaxel, Datopotamab Deruxtecan, Ds3790a, Combination Drug, Rosuvastatin, Bempedoic Acid, Ezetimibe, Ds9051b, Dato-Dxd, Ds3610a, Pembrolizumab, Ds5361b, Nab-Paclitaxel, Trastuzumab Deruxtecan, Paclitaxel, Capecitabine, Patritumab Deruxtecan, Liposomal Doxorubicin, Docetaxel, Prednisone, Ifinatamab Deruxtecan, Bempedoic Acid 180 Mg Tablet, Pembrolizumab, Pemetrexed, Trastuzumab Deruxtecan, Chemotherapy, Raludotatug Deruxtecan, Docetaxel, Enzalutamide, Abiraterone, Ifinatamab Deruxtecan, Mk-5684, Patritumab Deruxtecan, Pembrolizumab, Bevacizumab, Paclitaxel, Carboplatin, Raludotatug Deruxtecan, Rescue Medication, Quizartinib High Dose, Quizartinib Low Dose, Bevacizumab, Trastuzumab Deruxtecan, Pembrolizumab, Cyclophosphamide, Paclitaxel, Capecitabine, Carboplatin, Olaparib, Patritumab Deruxtecan, Doxorubicin Hydrochloride, Epirubicin Hydrochloride, Ifinatamab Deruxtecan, Raludotatug Deruxtecan, Docetetaxel, Docetaxel, R-Dxd, I-Dxd, Pembrolizumab, Oxaliplatin, Leucovorin, 5-Fluorouracil, Levoleucovorin, I-Dxd, Durvalumab, Ifinatamab Deruxtecan, Gocatamig, Quizartinib, Rufinamide, Quizartinib. These drug candidates are in various stages of clinical development as the company works toward FDA approval.